Abstract
THIS REPORT:
- Provides a comprehensive overview of the global market for cell and tissue
analysis products
- Offers a breakdown of the market by application including those for
diagnostics, basic research, drug screening and others
- Contains global market forecasts for cell and tissue analysis products,
with trends and forecasts for growth through 2014
- Discusses industry structure including key vendors, mergers and
acquisitions, distribution of products, government regulation and industry
trends
- Describes the latest technological advances including those in flow
cytometry, microscope based image analysis, high throughput screening (HTS)
devices and reagents and supplies.
INTRODUCTION
STUDY GOALS AND OBJECTIVES
This BCC Research report, Cell and Tissue Analysis Products: The Global
Market, provides a detailed analysis of the products and technologies that
define the market space and summarizes the composition and dynamics of
individual companies in the competitive environment. The study also includes
an overview of the relevant regulatory issues, patent landscapes, and
strategic partnerships that will play a role in shaping the market in the
future.
REASONS FOR DOING THE STUDY
The use of cells and tissue has been a mainstay of biomedical research since
the isolation and propagation of the HeLa cell in the 1950s. Along with the
recent emphasis on translational research in academia and demand for improved
clinical models during drug development and screening, the current use of
tissue and cells in the life sciences is at an all time high, creating intense
demand for upstream isolation and downstream analytical products in industrial
and academic markets.
Contemporary tissue repositories have vastly expanded their capacity and stock
breadth. Technological advances in cellular engineering now have the ability
to produce customized cell lines for specific research and industrial
applications. In parallel, the cell remains at the center of experimental
design in academia. All of these factors, as well as numerous others, have led
to increased demand for products used to isolate and analyze cells and tissue.
The recent surge in NIH and NSF funding, $10.4 billion and $3 billion,
respectively, stemming from President Obama' s stimulus package, will serve to
drive novel and existing domestic research programs. As innovative projects
get underway and new proposals are developed, the acute demand for products
associated with life-science research will increase accordingly. As a
corollary, due to the central role of cell and tissue analysis products in the
life-science research flow, this market report will be particularly timely.
SCOPE OF REPORT
The study scope of this report includes commercialized products used in the
isolation, purification, and analysis of cells, as well as novel products and
technologies that may be commercially viable by 2014. Biospecimens, enzymatic,
and mechanical tissue dissociation products, flow cytometry hardware and
software, magnetic cell separation products, laser microdissection (LMD)
systems, research antibodies, cell based assays and products used in high
content screening (HCS) platforms are included. Market growth forecasts
through 2014 are presented.
In addition to examining larger and more established producers in cell and
tissue analysis product market segments, BCC Research profiled numerous
smaller specialized market players in this report. Market segmentation within
the areas of biospecimen vendors, cell separation products and cell and tissue
analysis products are highlighted. Each technology is also analyzed by
application type and in the context of relevant technological and regulatory
forces to determine its current market status and forecast growth through
2014. Recent industrial alliances and acquisitions affecting producer market
penetration and dominance are also discussed.
BCC examines the structure of both the academic research and industrial
end-user markets predominantly in the U.S., but also in key international
markets. Important intellectual property holdings of industrial producers of
cell and tissue analysis products are also discussed.
INTENDED AUDIENCE
This report will be of general interest to business professionals in the field
of biotechnology. Both life science reagent suppliers and research scientists
will benefit from the comprehensive summary of relevant technologies and
industrial profiles contained here. Consultants, strategic and market
analysts, and investors working within the pharmaceutical, clinical and
biotechnology industries will also find this report particularly useful. In
addition, business development professionals, as well as those in sales,
marketing, information sciences, and competitive intelligence fields of
biotechnology will benefit from the information contained in this report.
METHODOLOGY AND INFORMATION SOURCES
The market assessments presented in this report were derived from publicly
available information up to and including April 2009. Using 2008 as the base
year, forecast data are provided through 2014. In cases where data for 2009
were incomplete or not readily available, figures were extrapolated from 2008
statistics, half-year figures for 2008, and historical trends between 2004 and
2008. Market figures are based on current U.S. dollars with no adjustments for
inflation made in the projections.
The information contained in this report has been assembled from both primary
and secondary data sources. Primary research was conducted via telephone
interviews with industry professionals, research scientists,
physician-researchers, and laboratory heads to discover the most recent
developments in their fields of interest. Secondary data was collected via a
comprehensive search of the scientific, peer-reviewed literature, clinical
trial reports and databases, industry trade media, company websites, annual
reports, intellectual property databases, and industry press releases.
| 
View Cart
